Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ANI in ANDA Pact with Sofgen | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

ANI in ANDA Pact with Sofgen

Will develop, market and distribute CV drug in U.S.

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

ANI Pharmaceuticals has signed a binding letter of intent for the development of an oral soft gel prescription product with Sofgen Pharmaceuticals. The product, indicated for cardiovascular health, will be the subject of an ANDA filing. Sofgen will be responsible for the development, manufacturing and regulatory submission of the product and ANI will be responsible for marketing and distribution in the U.S.

Arthur S. Przybyl, ANI’s president and chief executive officer, stated, “I am pleased to have entered into this collaboration with Sofgen for an oral soft gel drug. In addition to our internal product development efforts, we will continue to pursue opportunities through external partnerships and acquisitions in order to leverage our core capabilities in manufacturing and marketing. We are fortunate to have such a high quality partner in Sofgen.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics